![]() |
Volumn 43, Issue 1, 2002, Pages 211-213
|
Red cell aplasia due to erythrovirus parvovirus B19 infection in a Jehovah's witness with post-transplant EBV-induced aggressive lymphoma: Management considerations
a
a
|
Author keywords
Chemotherapy; Erythrovirus (Parvovirus) B19; Jehovah's Witness; Lymphoma; Post transplant lymphoproliferative disorder; PTLD; Renal transplant
|
Indexed keywords
ACICLOVIR;
ANTIBIOTIC AGENT;
ANTIVIRUS AGENT;
CLARITHROMYCIN;
COTRIMOXAZOLE;
CYANOCOBALAMIN;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
DOXORUBICIN;
ERYTHROPOIETIN;
FERROUS FUMARATE;
FOLIC ACID;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
TACROLIMUS;
VINCRISTINE;
ANTINEOPLASTIC AGENT;
ADULT;
ANEMIA;
ARTICLE;
B CELL LYMPHOMA;
BLOOD TRANSFUSION;
CASE REPORT;
CHRONIC KIDNEY FAILURE;
CHRONIC PYELONEPHRITIS;
DISEASE COURSE;
DISEASE SEVERITY;
ERYTHEMA INFECTIOSUM;
ERYTHROCYTE APLASIA;
HUMAN;
KIDNEY TRANSPLANTATION;
LARGE CELL LYMPHOMA;
MALE;
MEDICAL ETHICS;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
RELIGION;
DISEASE MANAGEMENT;
IMMUNOSUPPRESSIVE TREATMENT;
JEHOVAH'S WITNESS;
PARVOVIRUS;
PURE RED CELL ANEMIA;
VIROLOGY;
VIRUS INFECTION;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DISEASE MANAGEMENT;
EPSTEIN-BARR VIRUS INFECTIONS;
HUMANS;
IMMUNOSUPPRESSION;
JEHOVAH'S WITNESSES;
KIDNEY TRANSPLANTATION;
LYMPHOMA, B-CELL;
LYMPHOMA, LARGE-CELL, DIFFUSE;
MALE;
PARVOVIRIDAE INFECTIONS;
PARVOVIRUS B19, HUMAN;
RED-CELL APLASIA, PURE;
|
EID: 0036119563
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.1080/10428190210197 Document Type: Article |
Times cited : (4)
|
References (16)
|